WINTON GROUP Ltd boosted its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 234.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,900 shares of the conglomerate’s stock after acquiring an additional 44,110 shares during the period. WINTON GROUP Ltd’s holdings in Danaher were worth $14,399,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Sivia Capital Partners LLC increased its stake in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP increased its stake in Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after purchasing an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC increased its stake in Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC increased its stake in Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC increased its stake in Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
NYSE DHR opened at $184.45 on Friday. The firm has a market capitalization of $130.55 billion, a P/E ratio of 35.68, a PEG ratio of 2.49 and a beta of 0.81. The stock has a 50-day simple moving average of $181.29 and a two-hundred day simple moving average of $206.19. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
Analyst Ratings Changes
A number of research analysts have issued reports on DHR shares. DZ Bank started coverage on shares of Danaher in a research note on Wednesday. They set a “buy” rating and a $210.00 price target on the stock. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research note on Friday, April 17th. The Goldman Sachs Group cut their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Robert W. Baird cut their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $235.14.
Check Out Our Latest Stock Report on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- MarketBeat Week in Review – 06/01 – 06/05
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
